{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:16:52Z","timestamp":1778768212027,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["23NSFJQ0104"],"award-info":[{"award-number":["23NSFJQ0104"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0044\/2024\/ITP2,0001\/2024\/RDP"],"award-info":[{"award-number":["0044\/2024\/ITP2,0001\/2024\/RDP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20735"],"award-info":[{"award-number":["U24A20735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473289"],"award-info":[{"award-number":["82473289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biomaterials.2025.123466","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:03:50Z","timestamp":1748862230000},"page":"123466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficient cancer immunogenetherapy by tumor cell lysate modified mRNA formulation"],"prefix":"10.1016","volume":"324","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-4800","authenticated-orcid":false,"given":"Jieping","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9489-0142","authenticated-orcid":false,"given":"Xizi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1933-724X","authenticated-orcid":false,"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Zhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingmei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123466_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123466_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","article-title":"AAV gene therapy for tay-sachs disease","volume":"28","author":"Flotte","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2010.232","article-title":"Gene therapy of chronic granulomatous disease: the engraftment dilemma","volume":"19","author":"Grez","year":"2011","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123466_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2018-07-820720","article-title":"Update on clinical gene therapy for hemophilia","volume":"133","author":"Perrin","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12951-023-02044-5","article-title":"Emerging non-viral vectors for gene delivery","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123466_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043375","article-title":"Research status and prospect of non-viral vectors based on siRNA: a review","volume":"24","author":"Tong","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123466_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2025.123466_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"issue":"43","key":"10.1016\/j.biomaterials.2025.123466_bib11","volume":"32","author":"Lei","year":"2022","journal-title":"ALPPL2-Binding Peptide Facilitates Targeted mRNA Delivery for Efficient Hepatocellular Carcinoma Gene Therapy"},{"issue":"32","key":"10.1016\/j.biomaterials.2025.123466_bib12","doi-asserted-by":"crossref","first-page":"35835","DOI":"10.1021\/acsami.0c08268","article-title":"Surface-functionalized PEGylated nanoparticles deliver messenger RNA to pulmonary immune cells","volume":"12","author":"Ke","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123466_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2005191118","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2025.123466_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120431","article-title":"Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice","volume":"266","author":"Islam","year":"2021","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123466_bib15","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1172\/JCI134915","article-title":"mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer","volume":"130","author":"Cafri","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2025.123466_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121722","article-title":"Biomineralized hydrogel DC vaccine for cancer immunotherapy: a boosting strategy via improving immunogenicity and reversing immune-inhibitory microenvironment","volume":"288","author":"Huo","year":"2022","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123466_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s43018-021-00241-5","article-title":"Engineering enhanced CAR T-cells for improved cancer therapy","volume":"2","author":"Milone","year":"2021","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123466_bib19","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood.2021012811","article-title":"Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-Cell therapy in multiple myeloma","volume":"139","author":"Sakemura","year":"2022","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123466_bib20","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-21-0308","article-title":"The safety of bridging radiation with Anti-BCMA CAR T-Cell therapy for multiple myeloma","volume":"27","author":"Manjunath","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40425-019-0565-5","article-title":"Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen","volume":"7","author":"Wculek","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123466_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biomaterials.2018.08.016","article-title":"PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy","volume":"182","author":"Ochyl","year":"2018","journal-title":"Biomaterials"},{"issue":"7850","key":"10.1016\/j.biomaterials.2025.123466_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-021-03269-w","article-title":"Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance","volume":"591","author":"Tigano","year":"2021","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.biomaterials.2025.123466_bib24","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-019-0772-z","article-title":"Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression","volume":"38","author":"Bao","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2025.123466_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2017.01.016","article-title":"Interluekin-17A (IL17A)","volume":"614","author":"Chen","year":"2017","journal-title":"Gene (Amst.)"},{"key":"10.1016\/j.biomaterials.2025.123466_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-024-02617-7","article-title":"Single-cell RNA sequencing reveals myeloid and T cell co-stimulation mediated by IL-7 anti-cancer immunotherapy","author":"Eum","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123466_bib27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/CJI.0b013e31818213df","article-title":"Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy","volume":"31","author":"Hatfield","year":"2008","journal-title":"J. Immunother."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123466_bib28","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/1078-0432.CCR-13-1185","article-title":"A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside","volume":"19","author":"Chiang","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123466_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.smim.2010.02.004","article-title":"Whole tumor antigen vaccines","volume":"22","author":"Chiang","year":"2010","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123466_bib30","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.2147\/IJN.S319092","article-title":"Functionalized DMP-039 hybrid nanoparticle as a novel mRNA vector for efficient cancer suicide gene therapy","volume":"16","author":"Gao","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123466_bib31","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.2147\/IJN.S132780","article-title":"High drug-loading nanomedicines: progress, current status, and prospects","volume":"12","author":"Shen","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123466_bib34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni1109","article-title":"MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells","volume":"5","author":"LeibundGut-Landmann","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123466_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib36","article-title":"Immune cell identifier and classifier (ImmunIC) for single cell transcriptomic readouts","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123466_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-020-0731-4","article-title":"The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection","volume":"21","author":"Abbas","year":"2020","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123466_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110766","article-title":"Dynamic spectrum of ectopic lymphoid B cell activation and hypermutation in the RA synovium characterized by NR4A nuclear receptor expression","volume":"39","author":"Meednu","year":"2022","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123466_bib39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.immuni.2020.05.001","article-title":"Single-cell RNA sequencing of tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1alpha unleashes NK cell activity","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity (Camb., Mass.)"},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123466_bib40","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1073\/pnas.1805542115","article-title":"Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity","volume":"115","author":"Wu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123466_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108099","article-title":"Characterization of resident corneal plasmacytoid dendritic cells and their pivotal role in Herpes simplex keratitis","volume":"32","author":"Jamali","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123466_bib42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-020-0731-4","article-title":"The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection","volume":"21","author":"Abbas","year":"2020","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123466_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-Alpha inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123466_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","article-title":"NK cells at the interface between innate and adaptive immunity","volume":"15","author":"Moretta","year":"2008","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123466_bib45","first-page":"1165","article-title":"Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice","volume":"118","author":"Liu","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123466_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123466_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz8700","article-title":"Increased vaccine tolerability and protection via NF-kappaB modulation","volume":"6","author":"Moser","year":"2020","journal-title":"Sci. Adv."},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123466_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202201306","article-title":"Bifunctional fusion membrane-based hydrogel enhances antitumor potency of autologous cancer vaccines by activating dendritic cells","volume":"32","author":"Ke","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123466_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123466_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151239","article-title":"Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas","volume":"132","author":"Ogino","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2025.123466_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biomaterials.2016.10.047","article-title":"Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine","volume":"113","author":"Shi","year":"2017","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123466_bib52","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1039\/C9BM00010K","article-title":"Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy","volume":"7","author":"Wang","year":"2019","journal-title":"Biomater. Sci."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123466_bib53","doi-asserted-by":"crossref","first-page":"17543","DOI":"10.1073\/pnas.2005794117","article-title":"Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer","volume":"117","author":"Callmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123466_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.it.2019.06.004","article-title":"Dendritic cell metabolism and function in tumors","volume":"40","author":"Giovanelli","year":"2019","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123466_bib55","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.celrep.2016.07.076","article-title":"Differential intrasplenic migration of dendritic cell subsets tailors adaptive immunity","volume":"16","author":"Calabro","year":"2016","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123466_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.immuni.2008.08.006","article-title":"Mechanisms and consequences of dendritic cell migration","volume":"29","author":"Alvarez","year":"2008","journal-title":"Immunity (Camb., Mass.)"},{"key":"10.1016\/j.biomaterials.2025.123466_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100898","article-title":"Overcoming negatively charged tissue barriers: drug delivery using cationic peptides and proteins","volume":"34","author":"Vedadghavami","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2025.123466_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2018.07.017","article-title":"Strategies to overcome the polycation dilemma in drug delivery","volume":"136\u2013137","author":"Bernkop-Schnurch","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123466_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2021.01.014","article-title":"Polymeric delivery systems for nucleic acid therapeutics: approaching the clinic","volume":"331","author":"van den Berg","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123466_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igyarto","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.biomaterials.2025.123466_bib61","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.biomaterials.2018.03.036","article-title":"Engineering nanoparticle strategies for effective cancer immunotherapy","volume":"178","author":"Yoon","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123466_bib62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijbiomac.2021.02.130","article-title":"Cationic polymer-modified alhagi honey polysaccharide PLGA nanoparticles as an adjuvant to induce strong and long-lasting immune responses","volume":"177","author":"Wusiman","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"51","key":"10.1016\/j.biomaterials.2025.123466_bib63","doi-asserted-by":"crossref","first-page":"56731","DOI":"10.1021\/acsami.0c16357","article-title":"Cationic nanoparticle-mediated activation of natural killer cells for effective cancer immunotherapy","volume":"12","author":"Kim","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123466_bib64","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharm. Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225003850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225003850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:42:41Z","timestamp":1778766161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225003850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"alternative-id":["S0142961225003850"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123466","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient cancer immunogenetherapy by tumor cell lysate modified mRNA formulation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123466"}}